Screener
Cullinan Therapeutics, Inc. CGEM Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 7,436 | 8,860 |
| Total current assets | 341,974 | 386,756 |
| Property and equipment, net | 263 | 421 |
| Operating lease right-of-use assets | 2,233 | 2,630 |
| Other assets | 297 | 297 |
| Long-term investments | 19,020 | 58,270 |
| Total assets | $363,787 | $448,374 |
| Liabilities and Stockholders' Equity |
Item 1. Financial Statements.
FAQ
- What is Cullinan Therapeutics, Inc.'s operating lease ROU assets?
- Cullinan Therapeutics, Inc. (CGEM) reported operating lease ROU assets of $2.23M in Q2 2026.
- How has Cullinan Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Cullinan Therapeutics, Inc.'s operating lease ROU assets increased by 89.2% year-over-year, from $1.18M to $2.23M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Cullinan Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude